Position in NVS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$600,864
New position
Shares Held
3,834
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#810
of 1,603 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MW ADVISORY, LLC holds $7,908,251 across 8 Drug Manufacturers - General names. NVS ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,491 | $2,987,780 | |
| 2 | JNJ |
Johnson & Johnson
|
4,457 | $1,131,944 | |
| 3 | AMGN |
Amgen Inc
|
2,910 | $1,053,769 | |
| 4 | ABBV |
AbbVie Inc.
|
4,154 | $1,045,312 | |
| 5 | NVS |
Novartis AG
This page
|
3,834 | $600,864 | |
| 6 | AZN |
Astrazeneca PLC
|
2,376 | $450,537 | |
| 7 | MRK |
Merck & Co., Inc.
|
3,283 | $421,865 | |
| 8 | GSK |
GSK plc
|
4,124 | $216,180 |
All Filings in NVS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $600,864 | 3,834 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||